Just a few days ago, I posted about a study demonstrating statins more thn double the risk of developing diabetes.
I just stumbled upon another statin-related, blockbuster study. For some reason, this study came out in 2016 in the prestigious BMJ, yet I do not recall seeing/hearing any major news outlet report on it. Not only did the study found high “bad” cholesterol (LDL) to make people liver longer, study authors called cholesterol a “vital” molecules preventing infections, cancer, sarcopenia, etc. Considering that statins are perhaps the most prescribed drugs worldwide, then this extensive study with such blockbuster contrarian results, published in one of the most respected medical journals should have been front page news. Yet somehow, it went almost completely unnoticed. Since 2016, prescriptions for statins have increase by double digit percentage, which shows that a concerted censorship effort by pharma companies and their allies in the media business can easily silence even official sources of legitimate medical research. The recent move by Google to manipulate and scrub searches on natural health was bad enough but the silencing of such seminal BMJ front-page study goes above and beyond anything I have seen so far. Hopefully, the public is getting wiser and boycotting mainstream medicine, and that is why Google is resorting to such desperate censorship methods.
https://bmjopen.bmj.com/content/6/6/e010401.full
“…Cholesterol does not cause heart disease in the elderly and trying to reduce it with drugs like statins is a waste of time, an international group of experts has claimed. A review of research involving nearly 70,000 people found there was no link between what has traditionally been considered “bad” cholesterol and the premature deaths of over 60-year-olds from cardiovascular disease. Published in the BMJ Open journal, the new study found that 92 percent of people with a high cholesterol level lived longer. The authors have called for a re-evaluation of the guidelines for the prevention of cardiovascular disease and atherosclerosis, a hardening and narrowing of the arteries, because “the benefits from statin treatment have been exaggerated”.
“…Co-author of the study Dr Malcolm Kendrick, an intermediate care GP, acknowledged the findings would cause controversy but defended them as “robust” and “thoroughly reviewed”. “What we found in our detailed systematic review was that older people with high LDL (low-density lipoprotein) levels, the so-called “bad” cholesterol, lived longer and had less heart disease.” Vascular and endovascular surgery expert Professor Sherif Sultan from the University of Ireland, who also worked on the study, said cholesterol is one of the “most vital” molecules in the body and prevents infection, cancer, muscle pain and other conditions in elderly people. “Lowering cholesterol with medications for primary cardiovascular prevention in those aged over 60 is a total waste of time and resources, whereas altering your lifestyle is the single most important way to achieve a good quality of life,” he said. Lead author Dr Uffe Ravnskov, a former associate professor of renal medicine at Lund University in Sweden, said there was “no reason” to lower high-LDL-cholesterol.”
